Guerbet is a global leader in contrast media and solutions for diagnostic and interventional radiology, which includes the imaging of tumors in adults with known HCC, as well as microcatheter embolization of vascular anomalies.
In early 2018, Guerbet acquired Accurate Medical Therapeutics (“Accurate”). Accurate developed a range of microcatheters for embolization procedures on tumors or vascular diseases. Guerbet continues to invest in cutting edge technology, which aims to supplement our existing interventional imaging portfolio and other significant synergies with our range of products.
Overall, the focus of our Interventional Imaging franchise is to provide interventional radiologists with innovative image-guided and minimally invasive solutions that help advance the treatment of patients.